Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) EPS (Basic): 2023-2024

Historic EPS (Basic) for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $1.35.

  • Artiva Biotherapeutics' EPS (Basic) rose 109.07% to $1.35 in Q4 2024 from the same period last year, while for Dec 2024 it was -$38.81, marking a year-over-year change of. This contributed to the annual value of -$5.81 for FY2024, which is 83.76% up from last year.
  • Artiva Biotherapeutics' EPS (Basic) amounted to $1.35 in Q4 2024, which was up 246.74% from -$0.92 recorded in Q3 2024.
  • Artiva Biotherapeutics' 5-year EPS (Basic) high stood at $13.98 for Q3 2023, and its period low was -$22 during Q2 2024.
  • For the 2-year period, Artiva Biotherapeutics' EPS (Basic) averaged around -$8.68, with its median value being -$14.89 (2023).
  • The largest annual percentage gain for Artiva Biotherapeutics' EPS (Basic) in the last 5 years was 109.07% (2024), contrasted with its biggest fall of 106.58% (2024).
  • Quarterly analysis of 2 years shows Artiva Biotherapeutics' EPS (Basic) stood at -$14.89 in 2023, then surged by 109.07% to $1.35 in 2024.
  • Its EPS (Basic) stands at $1.35 for Q4 2024, versus -$0.92 for Q3 2024 and -$22 for Q2 2024.